(Q42992074)

English

A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C.

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

Marcello Persico

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Valerio Pazienza

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Angelo Andriulli

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

A Mangia

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

G L Ricci

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

N Minerva

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

V Carretta

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

D Bacca

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

M Cela

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

M Piattelli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

M Annese

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

G Maio

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

D Conte

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

V Guadagnino

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

F Spirito

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

292-299

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Antiviral drugs: current state of the art.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Pilot study of interferon-alpha high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Effect of ribavirin and amantadine on early hepatitis C virus RNA rebound and clearance in serum during daily high-dose interferon.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Clearance kinetics of hepatitis C virus under different antiviral therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Interferon plus amantadine versus interferon alone in the treatment of naı̈ve patients with chronic hepatitis C: a UK multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00591.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2005.00591.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850470%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42992074&oldid=1591781467"